D
Cullinan Therapeutics, Inc. CGEM
$8.74 -$0.33-3.64% NASDAQ
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

03/31/2025 12/31/2024 09/30/2024 06/30/2024 03/31/2024
Net Income -35.05% -9.28% 8.07% -0.28% -302.52%
Total Depreciation and Amortization -2.55% -1.29% 4.79% 40.27% 106.58%
Total Amortization of Deferred Charges -- -- -- -- --
Total Other Non-Cash Items 36.61% 17.17% -21.63% -19.62% 107.78%
Change in Net Operating Assets 150.14% -14.75% 78.06% 90.96% -179.58%
Cash from Operations -23.61% -8.21% 10.15% 21.40% 21.98%
Capital Expenditure -- -- 100.00% 100.00% 96.21%
Sale of Property, Plant, and Equipment -- -- -- -- --
Cash Acquisitions -- -- -- -- --
Divestitures -- -- -- -- --
Other Investing Activities -434.45% -478.50% -132.95% -159.57% 175.82%
Cash from Investing -434.94% -480.70% -127.69% -175.99% -85.37%
Total Debt Issued -- -- -100.00% -100.00% -100.00%
Total Debt Repaid -- -- -- -- --
Issuance of Common Stock 573.69% 595.26% 592.79% 565.50% 802.78%
Repurchase of Common Stock -- -- -- -- --
Issuance of Preferred Stock -- -- -- -- --
Repurchase of Preferred Stock -- -- -- -- --
Total Dividends Paid -- -- -- -- --
Other Financing Activities -12,455.56% -- 86.64% 88.61% 100.11%
Cash from Financing 561.98% 553.21% 3,389.05% 2,860.93% 244.65%
Foreign Exchange rate Adjustments -- -- -- -- --
Miscellaneous Cash Flow Adjustments -- -- -- -- --
Net Change in Cash 105.07% 73.27% 120.94% 87.34% -204.11%